Guidelines

Britain reported 2,911 confirmed measles cases in 2024, the highest number of cases recorded annually, since 2012.

The Canadian Healthcare Network is launching a dedicated page to all new Health Canada drug approvals so you can review the latest pharmaceutical treatment options at a glance.

Researchers introduce the “4S Pathway” to help manage diabetes regimens in older individuals experiencing difficulties with their current glycemic management approach.

A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts.

A commission of 58 medical experts made a distinction between preclinical and clinical obesity, cautioning against a blanket attribution of disease.

NACI issues updated guidance for use of human immunoglobulin products and vaccines for measles post-exposure prophylaxis.

Self-screening kits that have been adopted in British Columbia won’t be a part of the upcoming rollout in Ontario, which means patients still need to visit the doctor to get tested.

Glucagon-like peptide-1 receptor agonists have gone Hollywood.

But most not getting psychotherapy or alternatives to medication.

Robust guidelines from the American Society of Regional Anesthesia and Pain Medicine offer detailed recommendations to better prevent surgical site infections and, if needed, to treat them.